home / stock / lnth / lnth quote
Last: | $62.29 |
---|---|
Change Percent: | 3.03% |
Open: | $60.31 |
Close: | $60.46 |
High: | $62.375 |
Low: | $60.3 |
Volume: | 624,202 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$62.29 | $60.31 | $60.46 | $62.375 | $60.3 | 624,202 | 03-28-2024 |
$60.46 | $59.41 | $60.46 | $60.54 | $59.38 | 687,837 | 03-27-2024 |
$58.75 | $59.43 | $58.75 | $59.43 | $57.92 | 1,158,819 | 03-26-2024 |
$59.03 | $59.08 | $59.03 | $60.25 | $58.85 | 1,011,799 | 03-25-2024 |
$59.02 | $58.55 | $59.02 | $60.11 | $58.09 | 840,952 | 03-22-2024 |
$58.72 | $59.84 | $58.72 | $59.96 | $58.62 | 714,417 | 03-21-2024 |
$59.18 | $58.02 | $59.18 | $59.27 | $57.7808 | 687,613 | 03-20-2024 |
$58.44 | $56.75 | $58.44 | $59.42 | $56.52 | 1,319,444 | 03-19-2024 |
$56.52 | $58.63 | $56.52 | $58.63 | $56.44 | 1,117,328 | 03-18-2024 |
$58.17 | $59.78 | $58.17 | $60.54 | $57.8 | 1,485,668 | 03-15-2024 |
$59.83 | $59.97 | $59.83 | $60.2925 | $59.11 | 709,559 | 03-14-2024 |
$59.68 | $60.48 | $59.68 | $61.2799 | $59.52 | 646,529 | 03-13-2024 |
$60.88 | $62.75 | $60.88 | $62.967 | $60.82 | 641,702 | 03-12-2024 |
$62.72 | $62.51 | $62.72 | $63.25 | $61.25 | 816,027 | 03-11-2024 |
$62.52 | $63.03 | $62.52 | $65.4 | $62.43 | 1,036,518 | 03-08-2024 |
$62.59 | $61.96 | $62.59 | $63.1099 | $61.41 | 840,336 | 03-07-2024 |
$61.97 | $64.89 | $61.97 | $65.24 | $61.86 | 1,202,350 | 03-06-2024 |
$64.44 | $65.23 | $64.44 | $65.9 | $63.85 | 578,454 | 03-05-2024 |
$65.36 | $65 | $65.36 | $66.225 | $64.09 | 904,406 | 03-04-2024 |
$64.64 | $65.55 | $64.64 | $66.42 | $64.3 | 706,986 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter. "We ...
BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused c...
BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Paul Blanchf...